ArticleJournal of proteome research2013

The anticancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors.

Sudhakar Voruganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.